AML With Mutated NPM1 Clinical Trials

3 clinical trials for AML With Mutated NPM1 across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Dose Finding Study to Evaluate the Safety of BSB-2002 in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients With NPM1 Mutation — RECRUITING · PHASE1
• Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML — RECRUITING · PHASE1

Refine this search